Our team of clinical research professionals offers depth of experience that only a therapeutically focused CRO can offer in the area of neurological disorders like Alzheimer’s disease, Cognitive Disorders, Stroke, multiple sclerosis, Parkinson’s disease, schizophrenia etc. We are continue to set up new branches all over the world because of increasing demand for trusted medical research.


Our team understands the complexities of studying and treating patients suffering from neurolpogical disorders and is led by physicians and neurologists. Our strong relationships with leading psychiatrists, neurologists, and neuroscience investigators, has helped us conduct more than 20 neuroscience trials from Phase I through Phase IV programs, from single-site Phase I studies to large, global programs.


With significant unmet medical needs in the treatment of disease, cognitive disorders, stroke, multiple sclerosis, Parkinson’s disease, seizure disorder, schizophrenia, and other major neuroscience disorders, the demand for innovative therapies is high and expected to grow.


Alzheimer's disease
Multiple sclerosis
Parkinson's disease
Vascular Dementia
Traumatic Brain Injury
Neuropathic Pain